Cargando...

A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.

A double blind, crossover study of fibrinolytic enhancement treatment using stanozolol has been performed in primary Raynaud's phenomenon and in systemic sclerosis. The outcome criteria included subjective evaluation, clinical examination, physiological measurements of peripheral blood flow, an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Jayson, M I, Holland, C D, Keegan, A, Illingworth, K, Taylor, L
Formato: Artigo
Idioma:Inglês
Publicado: 1991
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1004323/
https://ncbi.nlm.nih.gov/pubmed/1994867
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!